Establishing surveillance for carbapenem- resistant enterobacteriaceae in Minnesota, 2012

Infection Control and Hospital Epidemiology

Volumn 35, Issue 4, 2014, Pages 451-453

  Shaw, Kristin M ^a   Harper, Jane E ^a   Vagnone, Paula Snippes ^a   Lynfield, Ruth ^a  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; IMIPENEM; MEROPENEM; CARBAPENEM DERIVATIVE;

ANTIBIOTIC SENSITIVITY; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; DISEASE SURVEILLANCE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EPIDEMIC; ESCHERICHIA COLI; INFECTION PREVENTION; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; UNITED STATES;

CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MINNESOTA; POPULATION SURVEILLANCE;

EID: 84895835998     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/675615     Document Type: Letter

References (10)

1. Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstreaminfections. Clin Microbiol Infect 2012;18(1):54-60.
2. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):1099-1106.
3. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52(3):1028-1033.
4. Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31(4):341-347.
5. Won SY, Munoz-Price LS, Lolans K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53(6):532-540.
6. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Wayne, PA: CLSI, 2012. CLSI document: M100-S22.
7. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30(5): 447-452.
8. Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol 2013;34(2):144-150.
9. Centers for Disease Control and Prevention. Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE): 2012 CRE Toolkit. http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf. 2012. Accessed August 19, 2013.
10. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-reisstant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52(7):848-855.